Most people in the longevity space run the process backward. They pick the compound first, then look for the problem it solves, and by the time anyone measures anything there's no baseline left to measure against. In this episode, Dr. Ethan Hausman-Marquis lays out The Catalyst Method — the rule that governs everything at The Catalyst Clinic: no data, no protocol. He walks through the full diagnostic panel, from the growth-hormone axis and metabolic markers to ApoB, Lp(a), thyroid antibodies, and full iron studies, and explains what each one is actually protecting against. The argument is blunt: two patients with identical symptoms, identical age, and identical goals can need opposite things, and the only thing that tells them apart is a number.

The second half turns to genetics, and to a distinction that rarely gets made out loud. Pharmacogenomics — how you metabolize what you're given — has published prescribing guidelines and changes decisions today. Monogenic risk findings like familial hypercholesterolemia change what you screen for and when, and often change outcomes for an entire family. But the sprawling wellness SNP panel is a different product with a different evidence base, and Ethan says so directly, along with the rule he applies to every test he orders: if a result won't change a decision, he shouldn't be charging for it. He also makes an on-air correction to how this topic is discussed across the industry, including by him.

Four composite cases close the episode: the executive whose baseline panel stopped a protocol before it started, the patient whose supplement shelf was quietly injuring her, the woman who spent years labeled "statin intolerant" over a single transporter variant, and the asymptomatic thirty-one-year-old whose lipid panel ended up putting three family members on treatment. Also covered: AURION, the system the clinic built to hold a hundred-plus data points in one view, and a clear account of what it does and doesn't decide.